Epidermal Transglutaminases
表皮转谷氨酰胺酶
基本信息
- 批准号:6823073
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:X ray crystallography calcium channel congenital ichthyosis crosslink enzyme activity enzyme mechanism enzyme structure fibroblasts human tissue immunoprecipitation inclusion body isozymes keratinization keratinocyte membrane proteins membrane structure molecular pathology myositis protein glutamine gamma glutamyltransferase protein structure function skin solubility structural biology tissue /cell culture transfection
项目摘要
Transglutaminases (TGases) catalyze the formation of a cross-link between a donor amide group of a protein-bound glutamine residue and an acceptor epsilon-NH2 of a protein-bound lysine residue. This cross-link is an isopeptide bond that cannot be cleaved in vertebrate organisms. The net result therefore is the formation of a permanent, stable, insoluble macromolecular protein complex. In the epidermis and other stratified squamous epithelia, several of the nine known TGase enzymes are expressed. In particular, TGases 1, 2 and 3 cross-link a variety of defined structural proteins to form the cornified cell envelope which is a principal component of epithelial barrier function. We are studying in detail each of these enzymes, and their roles in diseases.
Transglutaminase 1 The TGase 1 enzyme in cultured keratinocytes or foreskin epidermal cells is complex since it exists in multiple soluble and membrane-bound full-length as well as proteolytically-processed forms. Most of the enzyme is membrane bound by way of myristate and anchorages on the amino-terminal segment which is unique to the TGase 1 enzyme. The various forms display wide variations in specific activities, but these are difficult to measure because the enzyme is inherently unstable and easily degraded by proteolysis. To address structural and functional questions, we have been successful in expression in baculovirus systems. Previous work from this laboratory has shown that mutations in the TGM1 gene, encoding the TGase 1 enzyme, cause the autosomal recessive disorder lamellar ichthyosis. We examined its molecular basis in a Japanese family and reported two novel TGM1 mutations (R348X, and Y365D). Molecular docking studies revealed that the LI phenotype of this proband can be explained by the prediction that each of the maternally and paternally derived mutations will result in loss of enzyme activity. This study was published. In another investigation of this kind, two self-healing collodion baby siblings with markedly diminished epidermal TGM1 activity we were found to have compound heterozygous TGM1 mutations G278R and D490G. Molecular modeling and biochemical assays of mutant proteins under elevated hydrostatic pressure suggest significantly reduced activity in G278R and a chelation of water molecules in D490G that locks the mutated enzyme in an inactive trans conformation in utero. After birth these water molecules are removed and the enzyme is predicted to isomerize back to a partially active cis form, explaining the dramatic improvement of this skin condition. This study was also published
We have continued to perform structural analyses of TGase 3 by X-ray diffraction. In this way, we hope to gain a better understanding of the role of this enzyme in the skin. TGase 3 is expressed in many epithelial cell types, initially as an inactive pro-enzyme, that requires proteolytic activation by specific cleavage. To this end, we developed methods for the large-scale expression and purification of several forms of TGase 3 in the baculovirus system. These include the pro-enzyme, activated enzyme, and the 50 kDa active form. Over the past year, we focussed on regulatory effect of divalent cation binding. Specifically, we solved the structures of three forms of TGM3 in the presence of Ca2+ and/or Mg2+ which provide new insights on the contribution of each Ca2+ ion to activation and activity. First, we found that Ca2+ ion in site one can be exchanged with difficulty and it has a binding affinity of Kd= 0.3 mM, which suggests it is important for the stabilization of the enzyme. Site two can be occupied by some lanthanides but only Ca2+ of the Group 2 family of alkali earth metals, and its occupancy is required for activity. Site three can be occupied by some lanthanides, Ca2+ or Mg2+; however, when Mg2+ is present, the enzyme is inactive, and the channel is closed. Thus Ca2+ binding in both sites two and three cooperate in opening the channel. We speculate that manipulation of the channel opening could be controlled by intracellular cation levels. Together, these data have important implications for reaction mechanism of the enzyme: the opening of a channel perhaps controls access to and manipulation of substrates at the active site.
转氨酶(TGases)催化蛋白质结合的谷氨酰胺残基的供体酰胺基团和蛋白质结合的赖氨酸残基的受体ε-NH 2之间的交联的形成。这种交联是在脊椎动物生物体中不能被切割的异肽键。因此,最终结果是形成永久的、稳定的、不溶性的大分子蛋白质复合物。在表皮和其他复层鳞状上皮中,表达九种已知的TGase酶中的几种。特别地,TGases 1、2和3交联多种确定的结构蛋白以形成皮质细胞包膜,其是上皮屏障功能的主要组分。我们正在详细研究这些酶中的每一种,以及它们在疾病中的作用。
转氨酶1培养的角质形成细胞或包皮表皮细胞中的TGase 1酶是复杂的,因为它以多种可溶性和膜结合全长以及蛋白水解加工的形式存在。大多数酶通过肉豆蔻酸酯与膜结合,并锚定在TGase 1酶特有的氨基末端片段上。各种形式的比活性显示出广泛的变化,但这些是难以测量的,因为酶本身不稳定,容易被蛋白水解降解。为了解决结构和功能问题,我们已经成功地在杆状病毒系统中表达。本实验室以前的工作表明,编码TGase 1酶的TGM 1基因突变导致常染色体隐性遗传疾病板层状鱼鳞病。我们在一个日本家族中研究了其分子基础,并报告了两个新的TGM 1突变(R348 X和Y365 D)。分子对接研究表明,该先证者的LI表型可以解释为预测,每一个母亲和父亲衍生的突变将导致酶活性的损失。这项研究已经发表。在另一项类似的研究中,我们发现两个自愈的火棉胶婴儿兄弟姐妹的表皮TGM 1活性显著降低,他们具有复合杂合TGM 1突变G278 R和D490 G。分子建模和生物化学测定的突变蛋白质在静水压力升高的建议显着降低活性G278 R和螯合的水分子在D490 G锁定突变的酶在子宫内的非活性反式构象。出生后,这些水分子被去除,预计酶将异构化回到部分活性的顺式形式,这解释了这种皮肤状况的显着改善。这项研究还发表在
我们继续通过X射线衍射对TGase 3进行结构分析。通过这种方式,我们希望更好地了解这种酶在皮肤中的作用。TGase 3在许多上皮细胞类型中表达,最初作为无活性的前酶,需要通过特异性切割进行蛋白水解激活。为此,我们开发了在杆状病毒系统中大规模表达和纯化几种形式的TGase 3的方法。这些包括前酶、活化酶和50 kDa活性形式。在过去的一年里,我们专注于二价阳离子结合的调节作用。具体而言,我们解决了三种形式的TGM 3在Ca 2+和/或Mg 2+的存在下的结构,这为每个Ca 2+离子对活化和活性的贡献提供了新的见解。首先,我们发现位点1中的Ca ~(2+)离子可以很难交换,并且它具有Kd= 0.3mM的结合亲和力,这表明它对酶的稳定性很重要。位点2可以被一些镧系元素占据,但只有碱土金属的第2族的Ca 2+,并且其占据是活性所需的。位点3可以被一些镧系元素、Ca 2+或Mg 2+占据;然而,当Mg 2+存在时,酶是无活性的,并且通道是关闭的。因此,Ca 2+结合在两个网站2和3合作开放的通道。我们推测,操纵的通道开放可以控制细胞内阳离子水平。总之,这些数据对酶的反应机制具有重要意义:通道的打开可能控制活性位点处底物的进入和操纵。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER M STEINERT其他文献
PETER M STEINERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER M STEINERT', 18)}}的其他基金
EXPRESSION, STRUCTURE AND FUNCTION OF THE CORNIFIED CELL ENVELOPE
角质细胞包膜的表达、结构和功能
- 批准号:
6431735 - 财政年份:
- 资助金额:
-- - 项目类别:
Expression, Structure And Function Of The Cornified Cell
角质化细胞的表达、结构和功能
- 批准号:
6823072 - 财政年份:
- 资助金额:
-- - 项目类别:
STRUCTURAL FEATURES OF KERATIN AND RELATED INTERMEDIATE FILAMENTS
角蛋白及相关中间丝的结构特征
- 批准号:
6100520 - 财政年份:
- 资助金额:
-- - 项目类别:
Expression, Structure And Function Of The Cornified Cell
角质化细胞的表达、结构和功能
- 批准号:
6680158 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
- 批准号:
10668210 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
- 批准号:
10684558 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
- 批准号:
10628914 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
- 批准号:
10628911 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
- 批准号:
2200474 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
- 批准号:
452107 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
- 批准号:
10399417 - 财政年份:2021
- 资助金额:
-- - 项目类别: